Fig. 1 · Structure

Documents & Downloads

GW 441756

Cat. No. A16238 CAS 504433-23-2

TrkA inhibitor

GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM; little activity to c-Raf1 and CDK2.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
TrkA 2 nM
CDK2 >7 μM
C-Raf-1 >12 μM

Cellular Effect

Cell Line Activity Value Description Reference
Sf21 IC50 0.003 μM Inhibition of human N- terminal GST-tagged TrkA cytoplasmic domain (436 to 790 residues) expressed in baculovirus infected sf21 cells using biotinylated peptide substrate incubated for 15 mins followed by addition of ATP measured after 30 mins by TR-FRET [PMID: 27856237]
Sf9 IC50 2 nM Inhibition of human TrkA expressed in Sf9 cells by amplified luminescent proximity assay [PMID: 18646745]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 504433-23-2
Applications TrkA inhibitor
Formula C17H13N3O
Molecular Weight 275.31
SMILES
O=C1/C(C2=NC=CC=C2N1)=C\C3=CN(C)C4=C3C=CC=C4

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 25 mg/mL (90.81 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...